Crossmark

Costs and cost-effectiveness analysis of 2015 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults

Crossref DOI link: https://doi.org/10.1016/j.eimc.2015.07.012

Published Print: 2016-06

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Berenguer, Juan

Rivero, Antonio

Blasco, Antonio Javier

Arribas, José Ramón

Boix, Vicente

Clotet, Bonaventura

Domingo, Pere

González-García, Juan

Knobel, Hernando

Lázaro, Pablo

López, Juan Carlos

Llibre, Josep M.

Lozano, Fernando

Miró, José M.

Podzamczer, Daniel

Tuset, Montserrat

Gatell, Josep M.
Funding

Funding for this research was provided by:

Grupo de Estudio del SIDA (AIDS Study Group, GESIDA) of the Sociedad Española de Enfermedades Infecciosas y Microbiología Cínica

Red de Investigación en SIDA
License Information

Text and Data Mining valid from 2016-06-01
More Information

This article is maintained by: Elsevier

Article Title: Costs and cost-effectiveness analysis of 2015 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults

Journal Title: Enfermedades Infecciosas y Microbiología Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.eimc.2015.07.012

Content Type: article

Copyright: © 2015 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved.

Document is current

Any future updates will be listed below